The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

R Lazarus; S Baos; H Cappel-Porter; A Carson-Stevens; MC Clout; L Culliford; SR Emmett; J Garstang; L Gbadamoshi; B Hallis; RA Harris; D Hutton; CT Group

doi:10.2139/ssrn.3931758

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, MC Clout, L Culliford, SR Emmett, J Garstang, L Gbadamoshi, B Hallis, RA Harris, D Hutton, CT Group

Research output: Contribution to journal › Article (Academic Journal) › peer-review

Original language	English
Journal	The Lancet
DOIs	https://doi.org/10.2139/ssrn.3931758 https://doi.org/https://www.sciencedirect.com/science/article/pii/S0140673621023291
Publication status	Published - 30 Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Groups and Themes

BTC (Bristol Trials Centre)

Access to Document

Handle.net

Persistent link

Cite this

Lazarus, R., Baos, S., Cappel-Porter, H., Carson-Stevens, A., Clout, MC., Culliford, L., Emmett, SR., Garstang, J., Gbadamoshi, L., Hallis, B., Harris, RA., Hutton, D., & Group, CT. (2021). The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV). The Lancet. https://doi.org/10.2139/ssrn.3931758, https://doi.org/https://www.sciencedirect.com/science/article/pii/S0140673621023291

@article{077baeb5f1c34e5893365fb4a1f17c24,

title = "The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)",

author = "R Lazarus and S Baos and H Cappel-Porter and A Carson-Stevens and MC Clout and L Culliford and SR Emmett and J Garstang and L Gbadamoshi and B Hallis and RA Harris and D Hutton and CT Group",

year = "2021",

month = sep,

day = "30",

doi = "10.2139/ssrn.3931758",

language = "English",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

}

Lazarus, R , Baos, S, Cappel-Porter, H, Carson-Stevens, A, Clout, MC , Culliford, L, Emmett, SR, Garstang, J, Gbadamoshi, L, Hallis, B, Harris, RA, Hutton, D & Group, CT 2021, 'The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)', The Lancet. https://doi.org/10.2139/ssrn.3931758, https://doi.org/https://www.sciencedirect.com/science/article/pii/S0140673621023291

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV). / Lazarus, R ; Baos, S; Cappel-Porter, H et al.
In: The Lancet, 30.09.2021.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

AU - Lazarus, R

AU - Baos, S

AU - Cappel-Porter, H

AU - Carson-Stevens, A

AU - Clout, MC

AU - Culliford, L

AU - Emmett, SR

AU - Garstang, J

AU - Gbadamoshi, L

AU - Hallis, B

AU - Harris, RA

AU - Hutton, D

AU - Group, CT

PY - 2021/9/30

Y1 - 2021/9/30

UR - http://europepmc.org/abstract/PPR/PPR418587

UR - https://www.sciencedirect.com/science/article/pii/S0140673621023291

U2 - 10.2139/ssrn.3931758

DO - 10.2139/ssrn.3931758

M3 - Article (Academic Journal)

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -

Lazarus R , Baos S, Cappel-Porter H, Carson-Stevens A, Clout MC , Culliford L et al. The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV). The Lancet. 2021 Sept 30. doi: 10.2139/ssrn.3931758, https://www.sciencedirect.com/science/article/pii/S0140673621023291

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

UN SDGs

Research Groups and Themes

Access to Document

Handle.net

Other files and links

Cite this